Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now later-stage tilt small index

Spasticity: later-stage trial registry

3 of 9 indexed Spasticity trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #1,916 of 28,707 conditions by registered trial count.

9 US clinical trials · 3 currently recruiting · #1,916 of 28,707 conditions by registered trial count

Spasticity: 9 US clinical trials tracked, 3 recruiting.

Spasticity is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is The University of Texas Health Science Center, Houston, running 2 of these trials.

Enrollment posture brief

Registry condition spasticity

OPEN 3 | RECR 33% | LATE 3 | EARLY 1 | RANK #1916 | SPON 2

Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)

Acute Lymphoblastic Leukemia55.6%Acute Respiratory Distress S55.6%Spasticity (this)33%Acute Otitis Media22.2%Acute Heart Failure11.1%
Open-enrollment share among volume-matched conditions near Spasticity

Spasticity lists 3 open slots (33% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Spasticity on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Spasticity is recruiting below its size-band peers.

    3 of 9 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Spasticity research.

    The University of Texas Health Science Center, Houston accounts for 2 of 9 trials (22.2%). 8 distinct sponsors appear on at least one study for this condition label.

  3. Most Spasticity trials plan to enrol fewer than 100 people.

    Median target enrolment is 20 among the 9 trials that report a genuine target (sentinel values excluded). 7 of those (77.8%) plan for fewer than 100 participants.

  4. Spasticity research is mostly interventional.

    8 interventional and 1 observational studies make up this index (88.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 31Phase 42

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 3 1
Phase 4 2

Named interventions

Most-linked intervention names on Spasticity records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
2 trials
Rhizotomy for children with spasticity Procedure
1 trials
Botox Drug
1 trials
baclofen Drug
1 trials
arbaclofen Drug
1 trials
3-dimensional innervation zone (3DIZ) guided injection Device
1 trials
Standard BTX injection (ultrasound guided) Device
1 trials
Botulinum neurotoxin (BTX) Drug
1 trials

US sites by state

Facility locations filed on Spasticity trials. A trial with sites in several states counts in each.

Texas 3 trials
New York 3 trials
Kansas 3 trials
Michigan 2 trials
Maryland 2 trials
California 2 trials
Tennessee 1 trials
Pennsylvania 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Spasticity page

9 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Spasticity condition card totals 9 registered trials; most-linked intervention Placebo; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.